Physician profile
Mark R Hoeprich
NPI 1073714457
$21,257.22
in general payments reported to CMS, 2019-2025
19 companies · $11K in 2025
The $11K reported for 2025 was more than what 86% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $288 · 2020: $1,220 · 2021: $560 · 2022: $3,375 · 2023: $2,174 · 2024: $2,603 · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,800 · Travel and Lodging: $4,986 · Food and Beverage: $4,027.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,800.00 |
| Travel and Lodging | $4,986.36 |
| Food and Beverage | $4,027.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Monteris Medical Corporation | $8,378.70 | 2023-2025 | Neuroblate |
| Insightec,INC | $5,630.78 | 2022-2025 | Exablate |
| Abbott Laboratories | $3,389.90 | 2019-2025 | Infinity, Proclaim |
| Seaspine Orthopedics Corporation | $1,422.78 | 2022 | |
| Medtronic USA, INC. | $868.20 | 2019-2020 | |
| Nuvasive, INC. | $256.90 | 2021-2023 | |
| Nevro Corp. | $194.11 | 2021-2022 | |
| Brainlab, INC. | $193.15 | 2020-2025 | Brainlab, INC. |
| Globus Medical, INC. | $179.08 | 2024 | Xlif, Pulse |
| Medtronic, INC. | $174.03 | 2021-2024 | Intellis Adaptivestim, Stealthstation S8 Platform |
| Teva Pharmaceuticals USA, INC. | $121.83 | 2022 | |
| Olympus America INC. | $109.83 | 2025 | |
| Zimmer Biomet Holdings, INC. | $107.50 | 2025 | Rosa |
| Neuropace, INC. | $92.39 | 2024 | |
| Boston Scientific Corporation | $87.21 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Microtransponder, INC. | $25.53 | 2024 | |
| Integra Lifesciences Corporation | $25.30 | 2021 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Hoeprich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.